Trial
NCT07431398
Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fulcrum Therapeutics
Collaborators
—
Condition
Sickle Cell Disease
Intervention
Pociredir
Why stopped
Sponsor decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18